Citi analysts reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) stock and maintained a $125 price target. The ...

Citi analysts on Monday raised Broadcom Inc. (NASDAQ:AVGO)’s price target to $276 from $210 and reiterated a Buy rating for ...

Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish ...

Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...

CDW logged a -3.0% change during today's afternoon session, and is now trading at a price of $174.89 per share. The S&P 500 ...

Citigroup has reduced Regeneron Pharmaceuticals’ price target from $700 to $650, though it still maintains a “buy” rating.